We are live on
!
Find out more
ENZY
Enzymotec Ltd
ENZY
ENZY
Delisted
ENZY was delisted on the 10th of January, 2018.
34 hedge funds and large institutions have $67.3M invested in Enzymotec Ltd in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
180% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 5
13% more funds holding
Funds holding: 30 → 34 (+4)
23% less capital invested
Capital invested by funds: $87.8M → $67.3M (-$20.5M)
Holders
34
Holders Change
+4
Holders Change %
+13.33%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
14
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GS
Gagnon Securities
New York
|
+$2M |
| 2 |
Goldman Sachs
New York
|
+$1.66M |
| 3 |
GA
Gagnon Advisors
New York
|
+$1.58M |
| 4 |
LCM
Laurion Capital Management
New York
|
+$1.56M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$911K |
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
-$19.9M |
| 2 |
TM
Tiger Management
New York
|
-$4.69M |
| 3 |
Morgan Stanley
New York
|
-$356K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$329K |
| 5 |
Millennium Management
New York
|
-$73.3K |
